Society for Translational Medicine expert consensus on training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer

Liu, L.X. ; Mei, J.D. ; He, J. ; Gao, S.G. ; Li, S.Q. ; He, J.X. ; Huang, Y.C. ; Xu, S.D. ; Mao, W.M. ; Tang, Q.Y. ; Chen, C. ; Li, X.F. ; Zhang, Z. ; Jiang, G.N. ; Xu, L. ; Zhang, L.J. ; Fu, J.H. ; Li, H. ; Wang, Q. ; Liu, D.R. ; Tan, L.J. ; Zhou, Q.H. ; Fu, X.N. ; Jiang, Z.M. ; Chen, H.Q. ; Fang, W.T. ; Zhang, X. ; Li, Y. ; Tong, T. ; Yu, Z.T. ; Liu, Y.Y. ; Zhi, X.Y. ; Yan, T.S. ; Zhang, X.Y. ; Demmy, T.L. ; Berry, M.F. ; Perez, A.B.G. ; Cataneo, D. ; Bille, A. ; Licht, P. ; Kocher, G.J. ; Oncel, M. ; Evman, S. ; Jensen, K. ; Bagan, P. ; Embun, R. (Universidad de Zaragoza)

Resumen: Part I: basic contents of the projectOther Section
Project name
Training and certification standards for surgeons and assistants in minimally invasive surgery for lung cancer
Purpose and contents
Develop a training program for surgeons and assistants in minimally invasive surgery for lung cancer and establish clear criteria of certification.
Main issues
Training program for surgical assistants in minimally invasive surgery for lung cancer;
Training program for surgeons in minimally invasive surgery for lung cancer;
Certification of surgical assistants in minimally invasive surgery for lung cancer;
Certification of surgeons in minimally invasive surgery for lung cancer.

Part II: background and current statusOther Section
Background information
Lung cancer is one of the most common types of malignant tumor in China and is the leading cause of cancer deaths. Approximately 85% of lung malignancies are non-small cell lung cancer (NSCLC). Lung cancer treatments include surgery, chemotherapy, radiotherapy, and targeted therapy. The principle for advanced or complex cases is to combine non-operative therapies with surgery. Surgical resection is generally preferred for early stage lung cancer, and multimodality therapy is often combined with surgery for more locally advanced tumors with regional nodal involvement.
For decades, an open approach with thoracotomy has been the standard surgical treatment approach for lung cancer. In the early 1990s, Roviaro et al. (1) reported the first case of thoracoscopic lobectomy for lung cancer. Since then, minimally invasive surgery for lung cancer via the thoracoscopic approach has gradually emerged as an important advancement in thoracic surgery. Through the sequential progression from video-assisted thoracic surgery (VATS) via small incisions to multi-portal thoracoscopy, single utility port thoracoscopy, and single-port thoracoscopy, minimally invasive thoracoscopic surgery for lung cancer has matured and is now widely recognized as one of the standard surgical treatments for early stage lung cancers (2-4). Minimally invasive approaches in the surgical treatment of lung cancer have progressively expanded beyond lobectomy. Most procedures that involve parenchyma preservation, such as pulmonary artery sleeve lobectomy and tracheal tumor resection, can be achieved by thoracoscopy (5-7). After 20 years of development, accumulated evidence suggests that the perioperative results and long-term prognoses of patients undergoing thoracoscopic minimally invasive surgery for lung cancer are similar to or better than open thoracotomy (8-11).
For contemporary thoracic surgeons, minimally invasive surgery has therefore become a basic skill that must be mastered. As early as 2007, the National Health and Family Planning Commission in China proposed the implementation of pilot centers of “technical training and certification for endoscopy” which illustrates the importance of standardized training. However, there is still no systematic training system for theoretical study and thoracoscopic skills worldwide, nor are there technical standards of certification. The lack of these standards may lead to potential health risks for patients. Therefore, there is a need to develop standards for the training and certification of surgeons and surgical assistants in minimally invasive surgery for lung cancer.

Idioma: Inglés

DOI: 10.21037/jtd.2018.08.72

Año: 2018

Publicado en: Journal of thoracic disease 10, 10 (2018), 5666-5672
ISSN: 2072-1439

Factor impacto JCR: 2.027 (2018)

Categ. JCR: RESPIRATORY SYSTEM rank: 44 / 63 = 0.698 (2018) - Q3 - T3

Factor impacto SCIMAGO: 0.646 - Pulmonary and Respiratory Medicine (Q2)

Tipo y forma: Article (Published version)

Área (Departamento): Área Cirugía (Dpto. Cirugía,Ginecol.Obstetr.)